Table 1.

Clinical characteristics

	Patient 1	Patient 2	Patient 3	Patient 4
Demographics
Age, y	70	26	20	19
Sex	Female	Male	Male	Female
BMI, kg/m2	29.5	31.2	39.2	30.8
Disease history
Duration of disease, y	35	5	1	6
Tumor diameter at diagnosis, mm	NA	40	60	16
PRL at initial diagnosis, µ/L	NA	14 000	1347	113
Hormone deficiencies
Hypopituitarism	Yes	Yes	Yes	Yes
Adrenal insufficiency	No	No	Yes	No
Hypothyroidism	Yes	No	Yes	No
Hypogonadism	No	Yes	Yes	Yes
Treatment history
Surgeries, n	3	1	2	2
Radiotherapy	Yes	No	No	No
Temozolomide	Yes	No	No	No
Weekly cabergoline dose, mg	1	6	6	3

Abbreviations: BMI, body mass index; NA, not available; PRL, prolactin.